SU1498. VEGF-A 165 was twice as potent as VEGF-A 121 , which can be explained by the binding capacity of VEGF-A 165 to its co-receptor neuropilin-1 (NRP-1). Indeed, treatment with NRP-1 antagonist (GST-Ex7) reduced the effect of VEGF-A 165 to the levels observed upon stimulation with VEGF-A 121 . Finally, the use of selective PAF receptor antagonists reduced VEGF-A 165 -mediated P-selectin translocation. Together, these data show that maximal P-selectin translocation and subsequent neutrophil adhesion was mediated by VEGF-A 165 upon the activation of VEGFR-2/NRP-1 complex and required PAF synthesis. PlGF-1, PlGF-2 and VEGF-B bind to VEGFR-1; VEGF-C and D bind to VEGFR-2 and R-3; whereas VEGF-E interacts only with VEGFR-2 (5, 6; for reviews). Recent studies also reported that neuropilin-1 (NRP-1), a transmembrane receptor, acts as a coreceptor, complexing with VEGFR-1 and VEGFR-2 (7-10). NRP-1 specifically enhances the binding of VEGF-A 165 to VEGFR-2 and potentiates various VEGF-A 165 biological activities (8) . Such selectivity is attributable to the presence of VEGF-A exon 7 in VEGF-A 165 , a domain that is lacking in VEGF-A 121 , VEGF-C, VEGF-D and PlGF-1 (8, 11) . On the other hand, although NRP-1 can interact with PlGF-2 and VEGF-B isoforms, it does not potentiate their biological activities upon VEGFR-1 stimulation (9, 10).
We have recently shown that VEGF-A 165 permeability effect involves endothelial plateletactivating factor (PAF) synthesis (12) . We subsequently investigated the role of VEGF-A receptors, and showed that VEGF-A 165 induces EC migration, proliferation and PAF synthesis only.
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VEGF-mediated P-selectin translocation 4 through the activation of VEGFR-2, and that such effects can be potentiated by the expression of NRP-1 (13, 14) , whereas the activation of VEGFR-1 in the presence or absence of NRP-1 had no or marginal contribution on these activities (13, 14) .
The acute induction of PAF synthesis induced by VEGF-A 165 may also play a pivotal role in the interaction between inflammatory cells and ECs (15) (16) (17) (18) . Indeed, VEGF-A 165 , like other inflammatory mediators including histamine and thrombin, promotes the fusion of cytosolic Weibel-Palade bodies (WPB) with the plasma membrane, leading to the release of von Willebrand factor (vWf) and to a rapid and transient translocation of P-selectin to the endothelial apical surface (19) (20) (21) (22) (23) (24) . At the cell surface, P-selectin is able to interact with its high affinity counter-receptor, P-selectin-glycoprotein-ligand-1 (PSGL-1), on neutrophils to promote the rolling and transient adhesion of neutrophils (25, 26) . In addition, newly synthesized PAF, which remains associated with ECs (27) (28) (29) , may interact with PAF receptors on neutrophils (30) . Together, these interactions might enhance the adhesion of neutrophils to ECs, which is critical for the early/acute recruitment of leukocytes, and thus contribute to the induction of pathological angiogenesis (15) (16) (17) (18) .
In the present study, using VEGF analogs, in conjunction with selective inhibitors and antagonists, we studied the mechanisms whereby VEGF-A 165 promotes P-selectin translocation in HUVECs and the role of P-selectin and PAF in VEGF-A 165 -mediated neutrophil adhesion to ECs.
only.
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METHODS
Chemicals
Cell Culture
HUVEC were isolated from fresh umbilical cords and cultured as described previously (31) .
Briefly, HUVEC were seeded on gelatin-coated (0.25%) plates and cultured in DMEM/F-12 (3:2) medium containing 10% fetal bovine serum (FBS) (Hyclone Lab., Logan, UT.), EGM-2 singlequot without VEGF (Clonetics, Walkersville, MD.) and 2% antibiotics (Penicillin and Streptomycin; Sigma). HUVEC were characterized by cobblestone appearance and used at passage 1 or 2.
Confocal Microscopy
HUVECs were grown on glass coverslips, rinsed with DPBS (37 o C), stimulated with histamine or VEGF-A 165 , and fixed with 1% paraformaldehyde-DPBS solution. In another series of experiments, upon paraformaldehyde fixation, HUVEC were permeabilized with DPBS-Triton X-100 (0.5%). Nonspecific binding of primary antibodies was prevented by preincubating fixed only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From 6 HUVEC with 10% serum from the species used to raise the secondary antibodies. Cells were incubated with rabbit polyclonal anti-human P-selectin antibodies (1:100 Peroxidase activity was quantified at 450 nm using a plate reader. Nonspecific binding was assessed by substituting primary antibodies with normal rabbit serum (Santa Cruz Biotechnology, Santa Cruz, CA.). Western blot analyses were performed as described previously (13, 14) . Primary antibodies used were rabbit anti-human VEGFR-1, rabbit anti-mouse VEGFR-2, rabbit antihuman VEGFR-3, or goat anti-human NRP-1 IgG polyclonal antibodies (Santa Cruz Biotechnology). Membranes were stripped and reprobed to determine receptor phosphorylation (with the exception of NRP-1 as VEGF-A 165 , and its analogs, do not induce NRP-1 phosphorylation) (14) . Briefly, membranes were stripped using Re-Blot Plus Strong stripping solution (Chemicon International, Temecula, CA.) for 20 min, followed by a brief rinse with 0.1% TTBS. Following re-blocking, receptor tyrosine phosphorylation was determined as described above: the primary antiserum was mouse anti-phosphotyrosine clone 4G10 (1:4 000 dilution; Upstate Biotechnology Inc., Lake Placid, NY.). Kaleidoscope molecular weight markers (Bio-Rad) were used as molecular mass standards for SDS-PAGE immunoblotting experiments.
Neutrophil Purification
Venous blood was obtained from healthy donors, free from medication for at least 10 days before the experiments, as described previously (31) . This procedure yielded a neutrophil population that was 95% pure, as determined by a Coulter counter and Wright-Giemsa staining, and over 98% viable when assessed by trypan blue dye exclusion assay. were randomly selected and the neutrophils in each FOV were counted, recorded as the number of adhered neutrophils/mm 2 , as there were slight variations of basal neutrophil adhesion between experiments, we then reported our data as relative neutrophil adhesion (%).
Preparation of GST-VEGF-A 165 Exon 7 Fusion Protein
To assess the potential contribution of NRP-1 in potentiating the effects of VEGF-A 165 over VEGF-A 121 on P-selectin translocation and neutrophil adhesion to HUVEC, we produced a glutathione-S-transferase (GST) fusion protein encoding exon 7 of human VEGF-A 165 (GSTEx7). This sequence is not present in VEGF-A 121 and is responsible for the binding of VEGF-A 165 to NRP-1 (8) . The sequence encoding exon 7 of human VEGF-A 165 was cloned into the only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From 9 vector pGEX-2TK (Amersham Biosciences). Escherichia coli (DH5α) were transformed with pGEX-2TK or p2TK-exon 7 vectors to produce GST and GST-Exon 7 proteins. The recombinant proteins were purified from bacterial lysates using glutathione and heparin affinity chromatographies, as described previously (32) .
Measurement of PAF Synthesis
PAF production by HUVEC was measured by determining the incorporation of 3 H-acetate into lyso-PAF. Briefly, HUVEC were cultured to confluence in 6-well plates as detailed above, and stimulated with VEGF analogs (10 -9 M) for 7.5 min. Reactions were stopped and synthesized 3 H-PAF was extracted, purified by HPLC, and quantified by β-counting (33) .
Statistical Analysis
Data are presented as mean + s.e. mean. Statistical comparisons were made by analysis of variance, followed by a Bonferroni's t-test for multiple comparisons. Differences were considered significant when p <0.05.
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RESULTS
Localization of P-selectin and von Willebrand Factor in HUVEC
The subcellular localization of P-selectin and vWf was assessed by dual labeling, using selective antibodies against P-selectin and/or vWf, in conjunction with confocal microscopy. In control (DPBS)-treated HUVEC, we observed a homogenous cytosolic distribution of P-selectin and vWf ( Fig. 1A-C) . Treatment with VEGF-A 165 (10 -9 M) for 7.5 min induced a clustering of Weibel-Palade bodies (WPB) along the cytoplasmic membrane ( Fig. 1D-F) . As positive control, HUVEC were treated with histamine (10 -4 M) for 7.5 min, which promoted a clustering pattern of WPB similar to that observed in VEGF-A 165 -treated cells ( Fig. 1G-I ) (19, 24) . Negative control experiments performed with purified pre-immune rabbit and goat IgG as primary antibodies did not produce detectable staining (data not shown).
Effect of VEGF Analogs and Corresponding Receptors on P-selectin Translocation
The effect of VEGF analogs, plus the contribution of their receptors and the coreceptor NRP-1, on P-selectin translocation in HUVEC was assessed by cell surface ELISA. First, HUVEC were treated with VEGF-A 165 , and the time-(0-15 min; 10 -9 M) and dose-dependence (10 -12 to 10 -8 M;
7.5 min) of P-selectin translocation were determined. The accumulation of P-selectin at the cell surface reached a maximum following 7.5 min of stimulation and then declined ( Fig. 2A) . The optimum concentration of VEGF-A 165 was 10 -9 M, which increased cell surface P-selectin by up to 270% within 7.5 min (Fig. 2B) . Hence, these conditions were employed for the characterization of other VEGF analogs. VEGF-A 121 increased cell surface P-selectin by 135%
( 
Activation and Regulation of VEGF Receptors
As VEGF analogs induced P-selectin translocation, Western blot analyses were employed to both confirm the expression of VEGF receptors and NRP-1 in HUVEC and assess the capacity only.
For
P-selectin Translocation Mediated by VEGF Analogs: Role of VEGFR-1, VEGFR-2 and NRP-1
To assess the relative contributions of VEGFR-1 and VEGFR-2 in mediating P-selectin translocation, HUVECs were pretreated with a VEGFR-2 inhibitor, SU1498. Blockade of VEGFR-2 activation reduced VEGF-A 165 -and VEGF-A 121 -induced P-selectin translocation by 91 and 85%, respectively (Fig. 4A) . SU1498 was also efficient at preventing the effect of VEGF- (Fig. 4B) .
Contribution of PAF to VEGF-A 165 -induced P-selectin Translocation
We have previously shown that VEGF-A 165 induces PAF synthesis (12) . Furthermore, exposure of ECs to PAF promotes P-selectin translocation (31) . To determine whether PAF and its only.
For (Table 1) . VEGFR-1 agonists (PlGF-1, VEGF-B) had no effect on PAF synthesis (Table 1) .
We then examined if newly synthesized PAF, and its receptors, were involved in P-selectin translocation induced by VEGF-A 165 . Selective intra-, extra-and both intra-and extracellular PAF-receptor antagonists (LAU8080, BN 52021, and CV-3988) produced dose-dependent reductions in VEGF-A 165 -induced P-selectin translocation of, respectively, 39, 65 and 88% (Fig.   5A ). PAF induced P-selectin translocation and pretreatment with PAF receptor antagonists prior to a stimulation with PAF (10 -9 M) prevented P-selectin translocation by 88-95% (Fig. 5B) .
Treatment with PAF antagonists alone had no effect on basal P-selectin translocation (data not shown Fig. 3E and F ; lower bands).
Effect of VEGF Analogs and Corresponding Receptors on the Adhesion of Neutrophils to HUVECs: Role of P-selectin Translocation
As VEGF analogs induced P-selectin translocation, we wanted to assess their capacity to enhance the adhesion of neutrophils to HUVEC. (Fig. 6A) . Pretreatment of HUVECs with the P-selectin antagonist, rPSGL-Ig (10 ng -10 µg/ml) (32), 15 min prior to stimulation with VEGF-A 165 (10 -9 M; 7.5 min) resulted in a concentration-dependent inhibition of neutrophil adhesion to HUVEC (Fig. 6A) . At a concentration of 1 µg/ml, and in the presence of VEGF-A 165 (10 -9 M), rPSGL-Ig reduced neutrophil adhesion to basal levels (Fig. 6A) .
Treatment with normal mouse IgG (1 µg/ml) did not affect VEGF-A 165 -mediated neutrophil adhesion to HUVEC (Fig. 6A) .
To examine the effectiveness of VEGF analogs in promoting neutrophil adhesion, HUVECs (Fig. 6C) . Such pretreatment did not alter VEGF-A 121 -induced neutrophil adhesion (Fig. 6C) (Fig. 6C ).
GST-Ex7 or GST (10 -7 M) alone had no effect on basal neutrophil adhesion (data not shown).
Contribution of PAF to VEGF-A 165 -mediated Neutrophil Adhesion to HUVEC
As the activation of VEGFR-2 with selective VEGF analogs lead to PAF synthesis and the blockade of intra-and/or extracellular PAF receptors reduced VEGF-A 165 -mediated P-selectin translocation, the effect of PAFR antagonists upon neutrophil adhesion was examined.
Pretreatment with the intracellular PAFR antagonist, LAU8080 (up to 100 nM), reduced VEGF-A 165 -induced neutrophil adhesion by 94%, whereas an extracellular PAFR antagonist, BN 52021, or an antagonist of both intra-and extracellular PAFRs, CV-3988, completely prevented the adhesion of neutrophils to HUVEC (Fig. 7A) . When HUVEC were pretreated with the highest effective concentrations of PAF antagonists prior to a stimulation with PAF (10 -9 M), the adhesion of neutrophils to HUVEC was reduced by 81 to 96% (Fig. 7B) . Treatment with PAF antagonists alone had no effect on basal neutrophil adhesion to HUVEC (data not shown).
HUVEC and Neutrophil Viability
Finally, to insure that the blockade of P-selectin translocation and neutrophil adhesion to HUVEC produced by the agonists and antagonists employed in these studies were not due to a cytotoxic effect, the effect of all antagonists and inhibitors was assessed at the highest concentration used, either alone or in the presence of VEGF analogs on HUVEC and neutrophil viability by Trypan blue exclusion (data not shown). In all cases, the reagents and conditions employed herein did not increase cell mortality. Furthermore, no increase in detachment of HUVEC or the formation of membrane ghosts in HUVEC and neutrophils were detected up to 120 minutes post-treatment. Finally, by pretreating HUVECs with selective PAF receptor and P-selectin antagonists, we were able to demonstrate that PAF synthesis is essential for VEGF-A 165 -induced P-selectin translocation, which in turn is essential for the adhesion of neutrophils onto activated HUVECs.
VEGF Receptors Involvement in P-selectin Translocation
VEGF-C and VEGF-D, which activate VEGFR-2 and VEGFR-3, induced P-selectin translocation in HUVECs to about 30% of the maximal effect obtained with VEGF-A 165 (Fig. 2) . 
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(GST-Ex7) reduced the translocation of P-selectin mediated by VEGF-A 165 to the level mediated by VEGF-A 121 . Finally, pretreatment of HUVEC with SU1498 prior to stimulation with VEGF-A 121 or VEGF-A 165 reduced P-selectin translocation by 80-90% (Fig. 4A) . Therefore, in HUVECs, VEGFR-2 is favored over VEGFR-1 in mediating P-selectin translocation in response to VEGF-A isoforms, and the capacity to bind NRP-1 enhances effectiveness of VEGF-A 165 , as compared to VEGF-A 121 , to induce of P-selectin translocation.
Despite the fact that VEGF-A 165 and VEGF-A 121 activate both VEGFR-1 and VEGFR-2, in HUVECs, P-selectin translocation appears to be mediated predominantly by VEGFR-2. This is in agreement with previous reports suggesting that VEGFR-1 might act as a decoy receptor for VEGF-A 165 and VEGF-A 121 (13, 41) . Alternatively, VEGF-A isoforms may activate VEGFR-1 differently, compared to other VEGFR-1 agonists, resulting in a different profile of effector activation (9, (41) (42) (43) . This hypothesis is in agreement with our results, as VEGFR-1 agonists, VEGF-B and PlGF-1 increased cell-surface P-selectin to about 30% that produce by VEGF-A 165 .
Furthermore, Auterio and colleagues showed recently that VEGF-A 165 induced a strong phosphorylation of VEGFR-1 tyrosine (Tyr) residue Tyr1213 and to a lesser extent Tyr1242 and Tyr1333, whereas PlGF induced the phosphorylation of Tyr1309 but not Tyr1213 (44) . Such differences in the activation of VEGFR-1 by various agonists, termed 'agonist trafficking', might explain the distinct biological activities of VEGF-A 165 and its analogs.
Contribution of Endogenous PAF Synthesis on P-selectin Translocation
Stimulation of ECs with VEGF-A 165 , or other inflammatory mediators, leads to rapid and transient PAF synthesis. This newly formed PAF remains associated with ECs: 20% or less being exposed on the cell surface whereas the major portion remains inside the cell (12-14, 27- 29) . PAF-receptor (PAFR) antagonists have revealed that endogenous PAF acts as a second messenger to promote a rapid and transient synthesis of prostacyclin (PGI 2 ) and inducing c-fos and c-jun transcription (37) (38) (39) 45) . Consequently, we hypothesized that PAF, acting via cell membrane and/or intracellular PAFRs, might be involved in regulating P-selectin translocation.
VEGF analogs capable of activating VEGFR-2 doubled the cellular PAF content within 7.5 (Table 1) , whereas VEGFR-1-selective agonists (e.g., PlGF-1,VEGF-B) had no effect on PAF synthesis. Pretreatment with selective intra-, extra-, and both intra-and extracellular PAFreceptor antagonists prior to stimulation with VEGF-A 165 reduced P-selectin translocation by 39, 65 and 88%, respectively (Fig. 5A) . Together, our data demonstrate that VEGF-A 165 -induced Pselectin translocation is mediated by VEGFR-2 and may require the activation of both cell membrane and intracellular PAF receptors. It is unlikely that the blockade of VEGF-A 165 -induced P-selectin translocation by PAF receptor antagonists was due to cytotoxic or nonspecific effects as HUVEC viability and VEGFR-1/-2 phosphorylation were unaffected.
Furthermore, these antagonists have no effect on VEGF-A 165 -induced cGMP production (46) . Interestingly, VEGFR-1-selective agonists PlGF-1 and VEGF-B induced P-selectin translocation independent from PAF synthesis.
VEGF-mediated Neutrophil Adhesion to HUVEC is P-selectin-dependent
Previous reports have shown that endothelial P-selectin and PAF contribute to neutrophil adhesion in response to activation by inflammatory mediators (24) (25) (26) (27) (28) (29) (30) . Although the pivotal role played by P-selectin has been established, it is less clear whether PAF is essential. Some reports suggest that PAF might act in concert with P-selectin whereas others show that the blockade of P-selectin is sufficient to prevent neutrophil adhesion to EC (47) (48) (49) (50) 
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be explained by the fact that newly synthesized PAF, as shown in our study, appears to direct the translocation of P-selectin. Consequently, PAF synthesis is essential for the induction of Pselectin translocation but not for neutrophil adhesion.
This study demonstrates that treatment of HUVEC with VEGF-A 165 (10 -9 M), which induced maximal P-selectin translocation and PAF synthesis, increased the adhesion of neutrophils to HUVEC by over 300%. A P-selectin antagonist, rPSGL-Ig, resulted in complete inhibition of VEGF-A 165 -induced neutrophil adhesion (Fig. 6A ). Hence, P-selectin translocation is essential for the adhesion of neutrophils to activated EC whereas the interaction between endothelial PAF and PAF receptors expressed on neutrophils is not itself sufficient to support the adhesion of neutrophils to EC. These data strengthen the hypothesis, at least under static condition, that Pselectin itself is sufficient to promote neutrophil adhesion to activated ECs. However, we cannot rule out a role for PAF under conditions of shear stress in supporting the adhesion of neutrophils to activated ECs.
In conclusion, stimulation of VEGF receptors led to endothelial P-selectin translocation. The major pathway involved the VEGFR-2/NRP-1 complex by VEGF-A 165 and required PAF synthesis. Furthermore, PAF regulated P-selectin translocation via both autocrine and intracrine signaling. Interestingly, stimulation of VEGFR-1 either by PlGF-1 or VEGF-B lead to P-selectin translocation that was PAF-independent and of lesser magnitude than that included by VEGF-A 165 . Finally, the translocation of P-selectin to the surface of activated ECs was sufficient to support the adhesion of neutrophils, whereas PAF synthesis was essential for P-selectin translocation but not for neutrophil adhesion. Since the angiogenic properties of VEGF appear to be linked to increased vascular permeability, the increase in PAF synthesis and/or P-selectin only.
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